| Controlling type 2 diabetes mellitus with herbal medicines: A triple‐blind randomized clinical trial of efficacy and safety: 使用草药来控制 2 型糖尿病: 一项验证有效性与安全性的 … M Mirfeizi, Z Mehdizadeh Tourzani, SZ Mirfeizi, M Asghari Jafarabadi, ... Journal of diabetes 8 (5), 647-656, 2016 | 81 | 2016 |
| Non-addictive opium alkaloids selectively induce apoptosis in cancer cells compared to normal cells M Afzali, P Ghaeli, M Khanavi, M Parsa, H Montazeri, MH Ghahremani, ... DARU Journal of Pharmaceutical Sciences 23, 1-8, 2015 | 49 | 2015 |
| Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7 M Afzali, M Vatankhah, SN Ostad Journal of cancer research and therapeutics 12 (2), 725-730, 2016 | 37 | 2016 |
| The information needs of parents of children with cancer: A qualitative study S Borjalilu, Z Sharif, M Sabbagh Bani Azad, M Afzali, L Koochakzadeh Journal of Qualitative Research in Health Sciences 6 (3), 228-237, 2017 | 21 | 2017 |
| Precision medicine journey through omics approach M Hasanzad, N Sarhangi, S Ehsani Chimeh, N Ayati, M Afzali, F Khatami, ... Journal of Diabetes & Metabolic Disorders 21 (1), 881-888, 2022 | 15 | 2022 |
| Providing a framework for assessment of the access to medicine M Afzali, E Khorasani, M Alvandi, M Sabbagh-Bani-Azad, Z Sharif, ... DARU Journal of Pharmaceutical Sciences 27, 243-254, 2019 | 10 | 2019 |
| Controlling diabetes mellitus type 2 with herbal medicines: A triple blind, randomized clinical trial of efficacy and safety M Mirfeizi, Z Mehdizadeh Tourzani, SZ Mirfeizi, M Asghari Jafarabadi, ... J Diabetes, 1753-0407.12342, 2015 | 5 | 2015 |
| Evaluation of the expression of P-glycoprotein in propoxur-resistant Caco-2 cells. SNO Shabnam Yazdian, Najmeh Fahham, Mohammad Hossein Ghahremani, Monireh ... Acta Medica Iranica 52 (10), 728-733, 2014 | 4 | 2014 |
| Pharmacogenomics implementation and hurdles to overcome; in the context of a developing country N Ayati, M Afzali, M Hasanzad, A Kebriaeezadeh, A Rajabzadeh, S Nikfar Iranian Journal of Pharmaceutical Research: IJPR 20 (4), 92, 2021 | 3 | 2021 |
| Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension M Nosrati, NA Shahmirzadi, M Afzali, P Zaboli, H Rouhani, H Hamedifar, ... Journal of Family Medicine and Primary Care 9 (7), 3634-3638, 2020 | 2 | 2020 |
| Cost-effectiveness of ibrutinib as first-line treatment for older patients with chronic lymphocytic Leukemia in Iran S Fariman, FM Nasab, H Faraji, M Afzali Value in Health Regional Issues 38, 93-100, 2023 | 1 | 2023 |
| Toward a Recognition of Key Role players in Community Pharmacy M Afzali, A Rajabzadeh, S Ahmadi, F Soleymani, A Kebriaeezadeh, ... International Pharmacy Acta 6 (1), 1-8, 2023 | | 2023 |
| A conceptual model on the pharmacogenomics implementation complications: an applied qualitative research based on national drug policy components. N Ayati, M Afzali, M Hasanzad, A Kebriaeezadeh, AR Ghatari, S Nikfar | | 2022 |
| ارائه مدل مفهومی مرتبط با پیچیدگیهای پیشروی فارماکوژنومیکس در ایران: پژوهشی کیفی-کاربردی بر اساس مولفههای سیاست ملی دارویی N Ayati, M Afzali, M Hasanzad, A Kebriaeezadeh, AR Ghatari, S Nikfar Koomesh 24 (2), 245-254, 2022 | | 2022 |
| Influential Factors on Pharmacist Profession-Related Errors: a Community Pharmacy Approach: Pharmacist profession-related errors N Sarhangi, S Nikfar, SA Zakerian, M Afzali Iranian Journal of Pharmaceutical Sciences 17 (1), 19-26, 2021 | | 2021 |
| Economic Evaluations of Cabazitaxel for Treatment of Post-docetaxel Metastatic Castration-resistant Prostate Cancer: Evidence from a Systematic Review NA Shahmirzadi, P Zaboli, M Afzali, B Molla Tigabu, M Hajimiri, A Ajami, ... Journal of Pharmaceutical Research International 31 (6), 1-8, 2019 | | 2019 |
| PRS13 COST-UTILITY ANALYSIS OF MACITENTAN IN COMPARISON WITH BOSENTAN IN PULMONARY ATRIAL HYPERTENSION (PAH) M Nosrati, M Afzali, NA Shahmirzadi, P Zaboli, H Rouhani, ZG Achachloui, ... Value in Health 22, S874-S875, 2019 | | 2019 |
| Influential Factors on Pharmacist Profession-Related Errors: a Community Pharmacy Approach MA Nima Sarhangi, Shekoufeh Nikfar, Seyed Abolfazl Zakerian Iranian Journal of Pharmaceutical Sciences, 2019 | | 2019 |
| PIN49-THE COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VERSUS CASPOFUNGIN FOR CANDIDEMIA AND INVASIVE CANDIDIASIS TREATMENT: AN EXPERIENCE FROM IRAN M Afzali, S Zartab, P Zaboli, S Nikfar, M Boorboor Value in Health 21, S229, 2018 | | 2018 |
| Providing A Framework For Assessing Access To Medicine M Afzali, S Nikfar, M Alvandi, E Khorasani, M Sabbagh-Bani-Azad, ... Value in Health 20 (9), A658, 2017 | | 2017 |
Shekoufeh NikfarProfessor of Pharmacoeconomics, Tehran University of Medical Sciences (TUMS), IranVerified email at tums.ac.ir
